CSF2 and myxofibrosarcoma: Using TMA-assembled primary myxofibrosarcoma tissues, we validated the clinical relevance of the PAK1 gene copy number, PAK1 mRNA abundance, and immunoexpression levels of whole-cell PAK1, whole-cell and nuclear p-PAK1T423, and cytoplasmic CSF2.